Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Gastrointestinal 1

Conditions

Peripheral Nervous System Diseases 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 154Fluorouracil 138Gemcitabine 119Bevacizumab 115Leucovorin 106Specimen Handling 105Capecitabine 96pembrolizumab 90Magnetic Resonance Spectroscopy 82Nivolumab 80Cisplatin 80Irinotecan 72durvalumab 63Cetuximab 62Paclitaxel 60Biopsy 60130-nm albumin-bound paclitaxel 58Radiotherapy 49atezolizumab 44Albumin-Bound Paclitaxel 38Taxes 36Carboplatin 36Folfox protocol 34Drug Therapy 33lenvatinib 29dehydroftorafur 29sintilimab 28Cyclophosphamide 28tislelizumab 27Radiation 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Massage × Gastrointestinal × 90 days × Clear all
NCT02221700 2026-03-09

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

M.D. Anderson Cancer Center

Phase NA Active not recruiting
90 enrolled
BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡